"Pharmbudget 2025" is a real-world discussion between the government and the pharmaceutical industry
The highly anticipated "Pharmbudget 2025" Conference took place today, marking a significant event for the pharmaceutical community. This flagship gathering brought together company executives, importers, distributors, and pharmacy chains to gain insights into the industry's prospects for the coming year.
Dmytro Aleshko, managing partner of LA Law Firm, and Yevhenia Lukyanchuk, head of "APTEKA.ua Weekly," moderated a panel discussion on the critical dialogue between government authorities, regulatory bodies, and the pharmaceutical industry. Joined by representatives from the Ministry of Health of Ukraine, the American Chamber of Commerce in Ukraine, the European Business Association, and leading pharmaceutical companies, the panelists discussed emerging regulations and initiatives that could shape the industry's future.
Parallel imports and product labeling for medicines were among the primary issues debated at the panel discussion.